STOCK TITAN

P3 HEALTH PARTNERS INC Stock Price, News & Analysis

PIII Nasdaq

Welcome to our dedicated page for P3 HEALTH PARTNERS news (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 HEALTH PARTNERS stock.

P3 Health Partners Inc. (NASDAQ: PIII) is a physician-led, patient-centered population health management company that regularly issues news and updates related to its value-based care activities, Medicare membership, and financial performance. As a company focused on supporting primary care providers with care coordination and administrative services, P3’s news flow often highlights developments in its population health platform and provider network.

Investors and healthcare observers following PIII news can expect recurring coverage of quarterly earnings results, guidance updates, and discussions of non-GAAP metrics such as Adjusted EBITDA and medical margin. The company frequently reports on trends in at-risk Medicare membership, medical cost patterns, and the performance of its care enablement model across its markets.

P3 Health Partners also announces strategic partnerships and joint ventures, including the formation of P3 Commonwealth Innovation MSO, LLC with Commonwealth Primary Care ACO, LLC. Such releases describe how P3 engages in management, administration, and coordination of activities for accountable care organizations, including shared services, financial management, compliance operations, data analytics, and clinical integration.

Additional PIII news items cover participation in investor conferences, scheduling of earnings calls and webcasts, and operational milestones such as multi-state implementations with service partners. These updates provide insight into how P3 works with affiliated primary care providers, manages value-based arrangements, and navigates its multi-state footprint in markets such as Arizona, California, Nevada, and Oregon.

By reviewing the P3 Health Partners news page, readers can follow the company’s ongoing disclosures about its population health management strategy, financial results, ACO-related initiatives, and interactions with the investment community.

Rhea-AI Summary

P3 Health Partners (NASDAQ: PIII) and Commonwealth Primary Care ACO announced a joint venture management services organization on December 2, 2025 to expand value-based care for primary care physicians across Arizona, California, Nevada, Oregon, and North Carolina.

The JV preserves independent ACO entities, places P3 as the majority owner, and creates a unified operational platform combining P3’s Medicare Advantage/ACO/delegated risk capabilities with Commonwealth’s ACO REACH experience, while expanding P3’s footprint into Maricopa County, Arizona.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
partnership
-
Rhea-AI Summary

P3 Health Partners (NASDAQ: PIII) announced management will present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference on Wednesday, December 3, 2025 at 3:30 p.m. ET.

A live webcast of the presentation will be available on P3's investor relations website at https://ir.p3hp.org/. The presentation offers investors a chance to hear management remarks and a company update directly at the conference.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.12%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.14%
Tags
Rhea-AI Summary

P3 Health Partners (NASDAQ: PIII) will release third quarter 2025 financial results and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. Management will discuss results on a conference call at 5:00 AM PT / 8:00 AM ET the same day. The call is toll-free at 1-833-316-0546 (US) or 1-412-317-0692 (international), and will be webcast live from the company's Investor page at ir.p3hp.org.

The press release will be posted on the Investor page in advance of the call. An archived recording of the webcast will be available on the Investor page for 90 days after the conference call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.15%
Tags
conferences earnings
-
Rhea-AI Summary

P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in the upcoming Jefferies Healthcare Services Conference. The company's management team will engage in a fireside chat on September 30, 2025, at 2:25 PM Central Time.

Investors can access the presentation via webcast on P3's Investor Relations website, with a replay available for 30 days following the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.34%
Tags
conferences
-
Rhea-AI Summary

Catalyst Solutions (NYSE:PIII) has successfully launched its Professional Health Partners Services (P3) Implementation across four states. The implementation, completed in May 2025, supports P3 Health Partners in delivering population health management and administrative services for Medicare members.

The project spans Arizona, Oregon, Nevada, and California, covering eleven active health plans and serving nearly 68,000 members. Catalyst provides support through Configurations, Claims, and Provider Call Center services using a hybrid onshore/offshore model. The implementation was notably completed in just 60 days, demonstrating Catalyst's efficient execution capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.78%
Tags
none
Rhea-AI Summary

P3 Health Partners (NASDAQ: PIII) reported Q2 2025 financial results, demonstrating resilience in its core business despite industry challenges. The company achieved flat medical cost trends and recorded total revenue of $355.8 million, down 6% year-over-year. Average at-risk membership decreased 9% to 115,000 members due to network rationalization.

The company's medical margin was $30.6 million ($89 PMPM), while adjusted EBITDA showed a loss of $17.1 million ($50 PMPM). Notably, P3 has identified $120-$170 million in additional EBITDA opportunities for 2026. The company revised its FY2025 guidance, projecting total revenues between $1.35-$1.5 billion and adjusted EBITDA loss between $69-39 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.38%
Tags
-
Rhea-AI Summary

P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has scheduled its second quarter 2025 earnings release and conference call for August 14, 2025.

The company will release its Q2 2025 financial results and file its Form 10-Q on the same day. Management will host a conference call at 4:30 PM ET to discuss the results. Investors can access the call via toll-free number 1-833-316-0546 (US) or 1-412-317-0692 (International).

A live webcast will be available in the "Events & Presentations" section of P3's investor relations website. An archived recording will remain accessible for 90 days following the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
conferences earnings
-
Rhea-AI Summary
P3 Health Partners (NASDAQ: PIII) reported its Q1 2025 financial results, showing mixed performance. The company's revenue decreased 4% to $373.2 million compared to $388.5 million in Q1 2024. Average at-risk membership declined 8% to 115,900 members, while per-member funding PMPM increased 8% to $1,063. Medical margin fell to $17.2 million from $36.6 million, impacted by a $23 million negative adjustment from prior year claims. Adjusted EBITDA loss widened to $22.2 million from $19.8 million. Despite challenges, CEO Aric Coffman highlighted that three of four markets achieved breakeven or better in Q1, and the company's turnaround plan is ahead of schedule. P3 affirmed its 2025 guidance, projecting total revenues of $1.35-1.5 billion and at-risk members between 109,000-119,000.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.73%
Tags
Rhea-AI Summary

P3 Health Partners (NASDAQ: PIII) has announced it will release its first quarter 2025 financial results and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. The company will host a conference call with management to discuss the results at 4:30 PM ET/1:30 PM PT on the same day.

Investors can join the conference call through the toll-free number 1-833-316-0546 (US) or internationally at 1-412-317-0692. A live webcast will be available in the "Events & Presentations" section of P3's investor relations website. The webcast recording will remain accessible on the company's website for 90 days following the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
conferences earnings

FAQ

What is the current stock price of P3 HEALTH PARTNERS (PIII)?

The current stock price of P3 HEALTH PARTNERS (PIII) is $2.14 as of February 15, 2026.

What is the market cap of P3 HEALTH PARTNERS (PIII)?

The market cap of P3 HEALTH PARTNERS (PIII) is approximately 7.0M.

PIII Rankings

PIII Stock Data

7.03M
1.25M
Medical Care Facilities
Services-health Services
Link
United States
CHICAGO

PIII RSS Feed